Independent assessment for complex scientific, technical and strategic decisions.
When a decision involves unfamiliar technology, fragmented expertise, competing evidence or significant uncertainty, reynarun provides an independent assessment of what the evidence actually supports — and what it does not.
Discuss an Opportunity →The difficult part is often knowing which information matters, which claims deserve confidence, what remains uncertain, and how the pieces fit together.
reynarun provides independent scientific and technical assessment when the available expertise is fragmented, the evidence is difficult to interpret, or the consequences of a decision justify another level of scrutiny.
Identify the evidence, assumptions, technical issues and dependencies that can actually affect the decision.
Separate meaningful evidence from noise, unsupported claims, optimistic assumptions and information that does not change the decision.
Identify critical unknowns, evidence gaps, contradictions and risks before they become expensive surprises.
The goal is not to produce another pile of information. It is to establish a defensible understanding of the problem and determine what should happen next.
Which evidence and issues are genuinely decision-relevant?
Which assumptions, claims and information are distractions, weak signals or unsupported?
What remains unknown, contradictory or capable of changing the conclusion?
What conclusion can be supported, and what action follows from it?
Engagements can be narrowly defined or broad enough to evaluate an entire opportunity. The common requirement is independent judgment across information that may span multiple scientific, technical, operational and strategic domains.
Independent evaluation of scientific claims, technical approaches, evidence quality, development assumptions, limitations, dependencies and unanswered questions.
Explore scientific & technical assessment →Assess emerging technologies, platforms and technical approaches when the available expertise is distributed or difficult for a decision-maker to evaluate independently.
Explore technology assessment →Evaluate scientific rationale, translational potential, development assumptions, technical risks and evidence surrounding biotechnology, therapeutics, platforms and life sciences opportunities.
Explore biotechnology assessment →Assess research programs, portfolios and initiatives across scientific merit, strategic alignment, program design, dependencies, execution and measurable outcomes.
Explore research program evaluation →Independent scientific and technical perspective for investors evaluating companies, technologies, intellectual property, platforms or opportunities where domain expertise may be incomplete.
Explore investor due diligence →Some decisions do not fit neatly into a service category. Engagements can be structured around the actual decision, available information, required depth and urgency.
Discuss a specific question →What matters is not the label on the decision. It is whether the decision depends on evidence that requires careful interpretation across disciplines.
Evaluate scientific and technical assumptions before committing capital to an opportunity.
Understand what a technology can actually do, where it is immature, and what would need to be true for it to succeed.
Assess technical fit, evidence, dependencies, risks and the assumptions underlying a proposed relationship.
Provide independent scientific or technical perspective during transaction evaluation and due diligence.
Evaluate scientific direction, program design, priorities, dependencies and expected outcomes.
Examine unfamiliar opportunities where the information exists but the decision-maker lacks a unified view of the problem.
Test whether the available evidence supports the claims being made about a product, platform, technology or program.
Bring together distributed technical information when no single existing source provides the full picture.
Complex decisions often involve multiple specialists, reports, datasets, claims and competing interpretations. Each may be correct within its own domain while the decision-maker is still left without a coherent picture.
reynarun works across those boundaries. The objective is to understand the evidence in context, determine how the pieces interact, and distinguish what is genuinely important from what merely looks important.
The final product is not simply more analysis. It is a clearer basis for deciding what to do.
Define the decision, the opportunity, the available information and the questions that actually need to be answered.
Evaluate evidence, assumptions, technical claims, dependencies, risks, contradictions and information gaps.
Distill a large and potentially fragmented information set into the issues that genuinely affect the decision.
State what the evidence supports, what remains uncertain, and what should happen next.
reynarun is the current name of an independent consulting practice established in 2018. The brand is new; the underlying experience is not.
Jeremy Gawryluk brings doctoral training in pharmacology and physiology together with experience spanning translational science, neuroscience, biotechnology, rare disease, research program evaluation, research operations, funding, governance and interdisciplinary technical assessment.
That breadth matters because many difficult decisions do not belong entirely to one discipline. The value is in being able to enter an unfamiliar technical environment, understand the important pieces, challenge the evidence, and connect those pieces to the decision that needs to be made.
Tell us what you're looking at. We'll determine whether reynarun can help.